223 related articles for article (PubMed ID: 31511534)
1. E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance.
Cavaletti L; Taravella A; Carrano L; Carenzi G; Sigurtà A; Solinas N; Caro S; Stasio LD; Picascia S; Laezza M; Troncone R; Gianfrani C; Mamone G
Sci Rep; 2019 Sep; 9(1):13147. PubMed ID: 31511534
[TBL] [Abstract][Full Text] [Related]
2. E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in
Mamone G; Comelli MC; Vitale S; Di Stasio L; Kessler K; Mottola I; Siano F; Cavaletti L; Gianfrani C
Front Nutr; 2022; 9():974771. PubMed ID: 36159465
[TBL] [Abstract][Full Text] [Related]
3. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
[TBL] [Abstract][Full Text] [Related]
4. Efficient Hydrolysis of Gluten-Derived Celiac Disease-Triggering Immunogenic Peptides by a Bacterial Serine Protease from
Liu YY; Lee CC; Hsu JH; Leu WM; Meng M
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802942
[TBL] [Abstract][Full Text] [Related]
5. The human digestive tract has proteases capable of gluten hydrolysis.
Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB
Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325
[TBL] [Abstract][Full Text] [Related]
6. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
7. Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.
Francavilla R; De Angelis M; Rizzello CG; Cavallo N; Dal Bello F; Gobbetti M
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500039
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ
Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519
[TBL] [Abstract][Full Text] [Related]
9. A food-grade enzyme preparation with modest gluten detoxification properties.
Ehren J; Morón B; Martin E; Bethune MT; Gray GM; Khosla C
PLoS One; 2009 Jul; 4(7):e6313. PubMed ID: 19621078
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
[TBL] [Abstract][Full Text] [Related]
11. Development of wheat genotypes expressing a glutamine-specific endoprotease from barley and a prolyl endopeptidase from Flavobacterium meningosepticum or Pyrococcus furiosus as a potential remedy to celiac disease.
Osorio CE; Wen N; Mejias JH; Liu B; Reinbothe S; von Wettstein D; Rustgi S
Funct Integr Genomics; 2019 Jan; 19(1):123-136. PubMed ID: 30159724
[TBL] [Abstract][Full Text] [Related]
12. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.
Tye-Din JA; Anderson RP; Ffrench RA; Brown GJ; Hodsman P; Siegel M; Botwick W; Shreeniwas R
Clin Immunol; 2010 Mar; 134(3):289-95. PubMed ID: 19942485
[TBL] [Abstract][Full Text] [Related]
13. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.
Sestak K; Thwin H; Dufour J; Liu DX; Alvarez X; Laine D; Clarke A; Doyle A; Aye PP; Blanchard J; Moehs CP
Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367722
[TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
15. Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease.
Pultz IS; Hill M; Vitanza JM; Wolf C; Saaby L; Liu T; Winkle P; Leffler DA
Gastroenterology; 2021 Jul; 161(1):81-93.e3. PubMed ID: 33741317
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
[TBL] [Abstract][Full Text] [Related]
17. Proteomic modelling of gluten digestion from a physiologically relevant food system: A focus on the digestion of immunogenic peptides from wheat implicated in celiac disease.
Ogilvie O; Roberts S; Sutton K; Domigan L; Larsen N; Gerrard J; Demarais N
Food Chem; 2020 Dec; 333():127466. PubMed ID: 32659668
[TBL] [Abstract][Full Text] [Related]
18. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.
Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF
Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593
[TBL] [Abstract][Full Text] [Related]
19. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
20. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.
Caminero A; Galipeau HJ; McCarville JL; Johnston CW; Bernier SP; Russell AK; Jury J; Herran AR; Casqueiro J; Tye-Din JA; Surette MG; Magarvey NA; Schuppan D; Verdu EF
Gastroenterology; 2016 Oct; 151(4):670-83. PubMed ID: 27373514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
